Indiana University (NAL-C), Southwest Residency Program, Vincennes, Indiana; Department of Ophthalmology (LN), Beaumont Hospital-Royal Oak, Royal Oak, Michigan; and Department of Neurology and Ophthalmology (NRP, RP, BL, NJM, DIK), Michigan State University, East Lansing, Michigan.
J Neuroophthalmol. 2024 Jun 1;44(2):206-211. doi: 10.1097/WNO.0000000000001963. Epub 2023 Aug 4.
Studies suggest that weight gain is a prominent risk factor for recurrence of papilledema in idiopathic intracranial hypertension (IIH). Given this information, the significant weight gain that occurs during pregnancy, and the fact that pharmacologic therapy is many times discontinued, raises concerns for worsening edema and vision loss. To examine the impact of pregnancy weight gain on IIH, a retrospective chart review of patients with IIH and pregnancy was performed. Compared with previous studies, we 1) quantified findings with optical coherence tomography (OCT) and Humphrey visual field (HVF) data, 2) Included baseline data before pregnancy, 3) determined excess pregnancy weight gain using body mass index-adjusted weight gain goals, and 4) correlated worsening in IIH symptoms with changes in papilledema.
Charts were reviewed for patients with diagnoses of IIH who had at least 2 visits with neuro-ophthalmology during pregnancy. Thirteen patients met inclusion criteria. Data were compared from baseline visits before pregnancy, pregnancy visits, and postpregnancy visits.
Comparisons of HVF mean deviation (MD), OCT retinal nerve fiber layer (RNFL), and Max OCT RNFL during pregnancy were not significant compared with baseline ( P = 0.51, 0.41, and 0.25). Three patients were found to have increased papilledema during pregnancy (Max Avg OCT RNFL of 152.5, 129, and 123.5 μm) of which 2 developed new reproducible mild visual field defects (HVF ∆MD -1.78 and -4.49). All patients showed more than the 6% weight gain, typically observed in recurrent IIH. Eleven patients gained more than their weight from initial diagnosis. Eight patients had excess pregnancy weight gain. Six patients discontinued pharmacologic therapy for IIH.
Weight gain seems to carry a lower risk in IIH patients when associated with pregnancy. This is suggested by the high rate of stable or even decreased disc edema in patients despite medication discontinuation and excess pregnancy weight gain. We postulate these findings may be related to changes in weight distribution or endocrine changes during pregnancy.
研究表明,体重增加是特发性颅内高压(IIH)患者复发性视乳头水肿的一个显著危险因素。鉴于这一信息,怀孕期间体重显著增加,而且药物治疗往往多次中断,这引发了对水肿加重和视力丧失的担忧。为了研究妊娠体重增加对 IIH 的影响,我们对患有 IIH 和妊娠的患者进行了回顾性图表审查。与之前的研究相比,我们 1)使用光学相干断层扫描(OCT)和 Humphrey 视野(HVF)数据量化了发现结果,2)纳入了妊娠前的基线数据,3)使用体重指数调整后的体重增加目标来确定妊娠期间的额外体重增加,4)将 IIH 症状的恶化与视乳头水肿的变化相关联。
对至少有 2 次神经眼科妊娠就诊的 IIH 患者的病历进行了审查。符合纳入标准的有 13 名患者。比较了妊娠前基线就诊、妊娠就诊和产后就诊的数据。
与基线相比,妊娠期间 HVF 平均偏差(MD)、OCT 视网膜神经纤维层(RNFL)和 Max OCT RNFL 的比较没有显著差异(P = 0.51、0.41 和 0.25)。3 名患者在妊娠期间发现视乳头水肿增加(Max Avg OCT RNFL 分别为 152.5、129 和 123.5μm),其中 2 名患者出现新的可重复性轻度视野缺损(HVF ∆MD -1.78 和 -4.49)。所有患者的体重增加均超过 6%,这通常与复发性 IIH 有关。11 名患者的体重增加超过了最初诊断时的体重。8 名患者的妊娠体重增加过多。6 名患者停止了 IIH 的药物治疗。
当体重增加与妊娠相关时,它似乎对 IIH 患者的风险较低。这一点从以下事实得到证实:尽管药物治疗中断和妊娠期间体重增加过多,但大多数患者的视盘水肿仍稳定或甚至减轻。我们推测这些发现可能与怀孕期间体重分布或内分泌变化有关。